Karyopharm Therapeutics Inc
NASDAQ:KPTI
Karyopharm Therapeutics Inc
NASDAQ:KPTI
Price:
8.23
USD
-3.06%
Market Closed
Market Cap:
$150.7m
Wall Street
Price Targets
KPTI Price Targets Summary
Karyopharm Therapeutics Inc
Karyopharm Therapeutics Inc
Wall Street analysts forecast KPTI stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for
KPTI
is 15.71 USD
with a low forecast of 6.06 USD and a high forecast of 24.15 USD.
Lowest
Price Target
6.06
USD
26% Downside
Average
Price Target
15.71
USD
91% Upside
Highest
Price Target
24.15
USD
193% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is KPTI's stock price target?
Price Target
15.71
USD
15.71
USD
According to Wall Street analysts, the average 1-year price target for
KPTI
is 15.71 USD
with a low forecast of 6.06 USD and a high forecast of 24.15 USD.
What is Karyopharm Therapeutics Inc's Revenue forecast?
Projected CAGR
28%
28%
For the last 13 years the
compound annual growth rate for
Karyopharm Therapeutics Inc's revenue is
53%.
The projected
CAGR
for the next 3 years is
28%.
